
GC12124
Selonsertib
Also listed as Selonsertib (GS-4997)
Selonsertib (GS-4997) (GS-4997), an orally bioavailable, selective apoptosis signal-regulating kinase 1 (ASK1) inhibitor with a pIC50 of 8·3, has been evaluated as an experimental treatment for diabetic nephropathy and kidney fibrosis
ChemicalCAS1448428-04-3MW445.49FormulaC24H24FN7O
- CAS number
- 1448428-04-3
- Molecular weight
- 445.49
- Formula
- C24H24FN7O
- Solubility
- ≥ 44·5 mg/mL in DMSO, ≥ 88·8 mg/mL in EtOH
- InChIKey
- YIDDLAAKOYYGJG-UHFFFAOYSA-N
- Catalogue number
- GC12124
- Brand
- GLPBIO
Computed properties PubChem CID 71245288 · XLogP 2.7 · TPSA 90.5 Ų · H-bond donors 1
- XLogP
- 2.7
- TPSA
- 90.5 Ų
- H-bond donors
- 1
- H-bond acceptors
- 6
- Rotatable bonds
- 6
- Heavy atoms
- 33
SMILES CC1=CC(=C(C=C1N2C=C(N=C2)C3CC3)C(=O)NC4=CC=CC(=N4)C5=NN=CN5C(C)C)F
Computed descriptors from PubChem (CID 71245288), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il